<code id='4263C0F885'></code><style id='4263C0F885'></style>
    • <acronym id='4263C0F885'></acronym>
      <center id='4263C0F885'><center id='4263C0F885'><tfoot id='4263C0F885'></tfoot></center><abbr id='4263C0F885'><dir id='4263C0F885'><tfoot id='4263C0F885'></tfoot><noframes id='4263C0F885'>

    • <optgroup id='4263C0F885'><strike id='4263C0F885'><sup id='4263C0F885'></sup></strike><code id='4263C0F885'></code></optgroup>
        1. <b id='4263C0F885'><label id='4263C0F885'><select id='4263C0F885'><dt id='4263C0F885'><span id='4263C0F885'></span></dt></select></label></b><u id='4263C0F885'></u>
          <i id='4263C0F885'><strike id='4263C0F885'><tt id='4263C0F885'><pre id='4263C0F885'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:5
          Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage
          Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

          WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

          The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

          advertisement

          Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Why Eli Lilly’s earnings didn’t quite live up to the hype
          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          AMAs digital advisors table RPM coding reform proposal, again

          You’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthelifes